Annual Cash & Cash Equivalents
$19.40 M
-$95.13 M-83.06%
December 31, 2023
Summary
- As of February 24, 2025, NAUT annual cash & cash equivalents is $19.40 million, with the most recent change of -$95.13 million (-83.06%) on December 31, 2023.
- During the last 3 years, NAUT annual cash & cash equivalents has fallen by -$17.21 million (-47.01%).
- NAUT annual cash & cash equivalents is now -89.55% below its all-time high of $185.62 million, reached on December 31, 2021.
Performance
NAUT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.41 M
-$20.48 M-82.28%
September 30, 2024
Summary
- As of February 24, 2025, NAUT quarterly cash and cash equivalents is $4.41 million, with the most recent change of -$20.48 million (-82.28%) on September 30, 2024.
- Over the past year, NAUT quarterly cash and cash equivalents has dropped by -$69.69 million (-94.05%).
- NAUT quarterly cash and cash equivalents is now -98.47% below its all-time high of $288.39 million, reached on June 30, 2021.
Performance
NAUT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NAUT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.1% | -94.0% |
| 3 y3 years | -47.0% | -94.0% |
| 5 y5 years | -47.0% | -94.0% |
NAUT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.5% | at low | -97.9% | at low |
| 5 y | 5-year | -89.5% | at low | -98.5% | at low |
| alltime | all time | -89.5% | at low | -98.5% | at low |
Nautilus Biotechnology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.41 M(-82.3%) |
| Jun 2024 | - | $24.89 M(-3.3%) |
| Mar 2024 | - | $25.73 M(+32.6%) |
| Dec 2023 | $19.40 M(-83.1%) | $19.40 M(-73.8%) |
| Sep 2023 | - | $74.10 M(+2.7%) |
| Jun 2023 | - | $72.14 M(-18.5%) |
| Mar 2023 | - | $88.50 M(-22.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $114.52 M(-38.3%) | $114.52 M(-39.4%) |
| Sep 2022 | - | $188.93 M(-10.2%) |
| Jun 2022 | - | $210.35 M(+11.5%) |
| Mar 2022 | - | $188.62 M(+1.6%) |
| Dec 2021 | $185.62 M(+407.1%) | $185.62 M(-2.4%) |
| Sep 2021 | - | $190.24 M(-34.0%) |
| Jun 2021 | - | $288.39 M(+687.8%) |
| Dec 2020 | $36.61 M | $36.61 M |
FAQ
- What is Nautilus Biotechnology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Nautilus Biotechnology?
- What is Nautilus Biotechnology annual cash & cash equivalents year-on-year change?
- What is Nautilus Biotechnology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Nautilus Biotechnology?
- What is Nautilus Biotechnology quarterly cash and cash equivalents year-on-year change?
What is Nautilus Biotechnology annual cash & cash equivalents?
The current annual cash & cash equivalents of NAUT is $19.40 M
What is the all time high annual cash & cash equivalents for Nautilus Biotechnology?
Nautilus Biotechnology all-time high annual cash & cash equivalents is $185.62 M
What is Nautilus Biotechnology annual cash & cash equivalents year-on-year change?
Over the past year, NAUT annual cash & cash equivalents has changed by -$95.13 M (-83.06%)
What is Nautilus Biotechnology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NAUT is $4.41 M
What is the all time high quarterly cash and cash equivalents for Nautilus Biotechnology?
Nautilus Biotechnology all-time high quarterly cash and cash equivalents is $288.39 M
What is Nautilus Biotechnology quarterly cash and cash equivalents year-on-year change?
Over the past year, NAUT quarterly cash and cash equivalents has changed by -$69.69 M (-94.05%)